Research progress on the role of ferroptosis in the pathogenesis of non-alcoholic fatty liver disease

doi:10.16352/j.issn.1001-6325.2024.02.0260

Abstract

Abstract: Ferroptosis is a new type of cell death proposed in recent years, and its main characteristics are iron overload and lipid peroxidation. Ferroptosis is involved in the occurrence and development of non-alcoholic fatty liver disease(NAFLD). Iron overload can generate a large amount of reactive oxygen species through the Fenton reaction. Under the action of lipoxygenase, the unsaturated fatty acids on the liver cell membrane undergo lipid peroxidation, which induces liver cell death and leads to the occurrence of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. Blocking ferroptosis may provide one of the therapeutic strategies to protect liver cells.

Key words: ferroptosis, non-alcoholic fatty liver disease, lipid peroxidation, iron overload

CLC Number:

R589.2

XIAO Yanxin, LIU Yan, XU Lingling, ZHOU Yaru. Research progress on the role of ferroptosis in the pathogenesis of non-alcoholic fatty liver disease[J]. Basic & Clinical Medicine, 2024, 44(2): 260-264.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2024.02.0260

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2024/V44/I2/260

References

[1]Zhang L, Dai X, Wang L, et al. Iron overload accelerated lipid metabolism disorder and liver injury in rats with non-alcoholic fatty liver disease[J]. Front Nutr, 2022, 9:961892. doi:10.3389/fnut.2022. 961892.
[2]Wei S, Qiu T, Wang N, et al. Ferroptosis mediated by the interaction between Mfn2 and IREα promotes arsenic-induced nonalcoholic steatohepatitis[J]. Environ Res,2020,188:109824. doi: 10.1016/j.envres. 2020.109824.
[3]Hu Q, Wei W, Wu D, et al. Blockade of GCH1/BH4 axis activates ferritinophagy to mitigate the resistance of colorectal cancer to erastin-induced ferroptosis[J]. Front Cell Dev Biol,2022, 10:810327. doi:10.3389/fcell.2022.810327.
[4]Yu Y, Jiang L, Wang H, et al. Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis[J]. Blood, 2020, 136: 726-739. doi:10.1182/blood.2019002907. doi:10.1182/blood.2019002907.
[5]Hoki T, Miyanishi K, Tanaka S, et al. Increased duodenal iron absorption through up-regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic steatohepatitis[J]. Hepatology,2015,62:751-761. doi:10. 1002/hep.27774
[6]Sabrina N, Bai CH, Chang CC, et al. Serum iron: ferritin ratio predicts healthy body composition and reduced risk of severe fatty liver in young adult women[J]. Nutrients,2017,9:833. doi:10.3390/nu9080833.
[7]Wang L, Sun M, Cao Y, et al. miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload[J]. Arch Biochem Biophys, 2020, 695:108642. doi:10.1016/j.abb. 2020.108642.
[8]Lanthier N, Molendi-Coste O, Horsmans Y, et al. Kupf-fer cell activation is a causal factor for hepatic insulin resistance[J]. Am J Physiol Gastrointest Liver Physiol, 2010,298:107-116. doi:10.1152/ajp gi.00391.2009.
[9]Cheng K, Huang Y, Wang C. 1,25(OH)2D3 inhibited ferroptosis in zebrafish liver cells (ZFL) by regulating Keap1-Nrf2-GPx4 and NF-κB-hepcidin axis[J]. Int J Mol Sci,2021,22:11334. doi:10.3390/ijms 222111334.
[10]Zheng R, Lin C, Mao Y, et al. miR-761-hepcidin/Gpx4 pathway contribute to unexplained liver dysfunction in polycystic ovary syndrome by regulating liver iron overload and ferroptosis[J]. Gynecol Endocrinol, 2023,39:2166483. doi:10.1080/09513590.2023.2166483.
[11]Duan J, Wang Z, Duan R, et al. Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice[J]. Hepatology,2022,75:140-153. doi:10.1002/ hep.32148.
[12]Zhang XJ, She ZG, Wang J, et al. Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis[J]. Sci Transl Med,2021,13:eabg8117. doi:10.1126/scitranslmed.abg8117.
[13]Wenzel SE, Tyurina YY, Zhao J, et al. PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals[J]. Cell, 2017, 171:628-641.e26. doi:10.1016/j.cell.2017.09.044.
[14]Sun WY, Tyurin VA, Mikulska-Ruminska K, et al. Phospholipase iPLA2β averts ferroptosis by eliminating a redox lipid death signal[J]. Nat Chem Biol,2021,17:465-476. doi:10.1038/s41589-020-00734-x.
[15]兰斌,龚盛强,成绍武,等.铁死亡的机制及其在相关疾病中的意义[J].基础医学与临床,2018,38:1337-1341.doi:1001-6325(2018)09-1337-05.
[16]Zhu Z, Zhang Y, Huang X, et al. Thymosin beta 4 alleviates non-alcoholic fatty liver by inhibiting ferroptosis via up-regulation of GPX4[J]. Eur J Pharmacol,2021,908:174351. doi:10.1016/j.ejphar.2021. 174351.
[17]Gao G, Xie Z, Li EW, et al. Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis[J]. J Nat Med, 2021,75:540-552. doi:10. 1007/s11418-021-01491-4.
[18]Yang Y, Chen J, Gao Q, et al. Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease[J]. Toxicology, 2020, 445:152599. doi:10.1016/j.tox.2020. 152599.
[19]Chen GH, Song CC, Pantopoulos K, et al. Mitochondrial oxidative stress mediated Fe-induced ferroptosis via the NRF2-ARE pathway[J]. Free Radic Biol Med, 2022,180:95-107. doi:10.1016/j.freeradbiomed.2022.01. 012.
[20]Qi J, Kim JW, Zhou Z, et al. Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation-mediated cell death in mice[J]. Am J Pathol, 2020,190:68-81. doi:10.1016 /j.ajpath.2019.09.011.
[21]Tong J, Li D, Meng H, et al. Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease[J]. Acta Pharm Sin B, 2022, 12:3 650-3666. doi:10.1016/j.apsb.2022.02.003.
[22]Li S, Zhuge A, Wang K, et al. Obeticholic acid and ferrostatin-1 differentially ameliorate non-alcoholic steatohepatitis in AMLN diet-fed ob/ob mice[J]. Front Pharmacol, 2022, 13:1081553. doi:10.3389/fphar.2022. 1081553.
[23]Anthonymuthu TS, Tyurina YY, Sun WY, et al. Resolv-ing the paradox of ferroptotic cell death: Ferrostatin-1 binds to 15LOX/PEBP1 complex, suppresses generation of peroxidized ETE-PE, and protects against ferroptosis[J]. Redox Biol, 2021,38:101744. doi:10.1016/j.redox.2020. 101744.
[24]Kim JH, Lewin TM, Coleman RA. Expression and characterization of recombinant rat Acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones[J]. J Biol Chem, 2001,276:24667-24673. doi:10.1074/jbc.M010793200.
[25]Carlson BA, Tobe R, Yefremova E, et al. Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration[J]. Redox Biol,2016,9:22-31. doi:10.1016/j.redox.2016.05.003.
[26]Anegawa D, Sugiura Y, Matsuoka Y, et al. Hepatic resistance to cold ferroptosis in a mammalian hibernator Syrian hamster depends on effective storage of diet-derived α-tocopherol[J]. Commun Biol, 2021,4:796. doi:10.1038/s42003-021-02297-6.